Industry Verticals »

All Categories

Insights »

About TMR »

Parenteral Nutrition Market Insights, 2019-2027

Parenteral Nutrition Market (Type of Nutrition - Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes and Minerals, Vitamins) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global parenteral nutrition market for the historical period 2017–2018 and forecast period 2019–2027, rising incidence of chronic diseases and growing approvals to novel parenteral nutrition components are projected to drive the global market during the forecast period
  • According to the report, the global market was valued at US$ 5.6 Bn in 2018 and is anticipated to grow at a CAGR of 4.6% from 2019 to 2027
fa global parenteral nutrition market

High Incidence and prevalence of chronic diseases across the globe: Key Driver

  • High prevalence and rise in incidence rate of chronic diseases across the globe is a key factor driving the global parenteral nutrition market.
  • The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also fuelled the consumption of parenteral nutrition in recent years
  • For instance, according the National Kidney Foundation stated around 10% of the world’s population is affected by chronic kidney disease each year.
  • Furthermore, rise in cases of malnutrition among the geriatric population is fuelling the growth of global market.
  • For instance, as per the National Resource Center on Nutrition, Physical Activity & Aging, around 1 million housebound older people are malnourished every year in North America
  • Moreover increase in approvals of novel parenteral components and rise in research & development activities by major companies for new product development are some of the major factors responsible for the growth of global market.

Side effects and complications related to parenteral nutrition products hamper the market growth

  • Inappropriate usage of parenteral nutrition maximizes the potential risk of adverse events such as refeeding syndrome, particulate contamination, catheter infections, and liver dysfunction to the patients undergoing the therapy. This factor can restrain the market growth.
  • For instance, an article published by the American Society for Nutrition in 2014 indicated that long-term parenteral nutrition therapy significantly increases the risk of liver disease and metabolic complications in patients.  

North America dominated the global market

  • On the basis of region, the parenteral nutrition market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
  • North America region dominated the global market owing to higher prevalence of chronic diseases such as cancer, diabetes in the region, growing approval of U.S. FDA approved parenteral nutrition products in recent years, and higher R&D investment funding by major companies.
  • However, Asia-Pacific region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly ascribed to factors such as growing aging population which is more prone to chronic diseases, growing awareness of parenteral nutrition, and improving healthcare infrastructure in the region.

Global Parenteral nutrition Market: Competitive Landscape

  • This report profiles major players in the market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global market is highly consolidated, with a few global players accounting for a major share in market.
  • Leading players operating in the global parenteral nutrition industry are
    • Allergan plc.
    • Pfizer Inc.
    • B.Braun Melsungen AG
    • Fresenius Kabi AG
    • Grifols, S.A.
      Baxter International, Inc.
    • Vifor Pharma Management Ltd.
    • Sichuan Kelun Pharmaceutical Co., Ltd., 

Key Developments

Key players in the global parenteral nutrition market are engaged in regulatory approvals, new product development, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market. A few expansion strategies adopted by players operating in the market are:

  • In 2018, Fresenius Kabi AG has launched mofKabiven extra Nitrogen, a three-chamber bag with a special protein-energy ratio, in Europe.
  • In July, 2017, Baxter International, Inc., has acquired Claris Injectables Limited, which was a wholly owned subsidiary of Claris Lifesciences Limited.

The report on the global parenteral nutrition market discussed individual strategies, followed by company profiles of manufacturers of parenteral nutrition. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global parenteral nutrition industry.

Global Parenteral Nutrition market – Segmentation

Type

Carbohydrates

Parenteral Lipid Emulsions

Single Dose Amino Acid Solutions

Trace Elements, Electrolytes & Minerals

Vitamins

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the anticipated CAGR of the parenteral nutrition market in the forecast period?

It is anticipated to expand at a CAGR of 4.6% to 2019 to 2027

What are the key driving factors for the growth of the market?

Parenteral nutrition market is driven by rising incidence of chronic diseases and growing approvals to novel parenteral nutrition components

Which region is expected to project the highest market share in the global market?

North America region dominated the global market owing to higher prevalence of chronic diseases

Which is the rising prominent segment in the market for parenteral nutrition?

The single dose amino acid solutions segment accounted for leading market share

Who are the key players in the global parenteral nutrition industry?

Baxter International, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., Vifor Pharma Management Ltd., Grifols, S.A., Fresenius Kabi AG, B.Braun Melsungen AG, Pfizer Inc., and Allergan plc.

    1. Preface

            1.1. Market Definition and Scope

            1.2. Market Segmentation

            1.3. Key Research Objectives

            1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Parenteral Nutrition Market

    4. Market Overview

            4.1. Introduction

                4.1.1. By Type  Introduction

                4.1.2. Industry Evolution / Developments

            4.2. Overview

            4.3. Market Dynamics

                4.3.1. Drivers

                4.3.2. Restraints

                4.3.3. Opportunities

            4.4. Global Parenteral Nutrition Market Analysis and Forecasts, 2017–2027

                4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook

            5.1. Clinical Trial Pipeline Analysis

            5.2. Key Mergers & Acquisitions

            5.3. Cancer Diseases Epidemiology Analysis, by Key Country/Region

            5.4. Inflammatory Bowel Diseases Epidemiology Analysis, by Key Country/Region

            5.5. Preterm Birth Epidemiology Analysis, by Key Country/Region

    6. Global Parenteral Nutrition Market Analysis and Forecast, by Type  

            6.1. Introduction & Definition

            6.2. Key Findings / Developments

            6.3. Global Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

                6.3.1. Carbohydrates

                6.3.2. Parenteral Lipid Emulsions

                6.3.3. Single Dose Amino Acid Solutions 

                6.3.4. Trace Elements, Electrolytes, & Minerals

                6.3.5. Vitamins

            6.4. Global Parenteral Nutrition Market Attractiveness, by Type, 2019-2027  

    7. Global Parenteral Nutrition Market Analysis and Forecast, by Region

            7.1. Key Findings

            7.2. Global Parenteral Nutrition Market Value Forecast, by Region

                7.2.1. North America 

                7.2.2. Europe 

                7.2.3. Asia Pacific 

                7.2.4. Latin America 

                7.2.5. Middle East & Africa 

            7.3. Global Parenteral Nutrition Market Attractiveness, by Region, 2019-2027

    8. North America Parenteral Nutrition Market Analysis and Forecast

            8.1. Introduction

                8.1.1. Key Findings

            8.2. North America Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

                8.2.1. Carbohydrates

                8.2.2. Parenteral Lipid Emulsions

                8.2.3. Single Dose Amino Acid Solutions 

                8.2.4. Trace Elements, Electrolytes, & Minerals

                8.2.5. Vitamins

            8.3. North America Parenteral Nutrition Market Value Forecast, by Country, 2017–2027

                8.3.1. U.S.

                8.3.2. Canada

            8.4. North America Parenteral Nutrition Market Attractiveness Analysis, 2019-2027 

                8.4.1. By Type  

                8.4.2. By Country

    9. Europe Parenteral Nutrition Market Analysis and Forecast

            9.1. Introduction

                9.1.1. Key Findings

            9.2. Europe Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

                9.2.1. Carbohydrates

                9.2.2. Parenteral Lipid Emulsions

                9.2.3. Single Dose Amino Acid Solutions 

                9.2.4. Trace Elements, Electrolytes, & Minerals

                9.2.5. Vitamins

            9.3. Europe Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

                9.3.1. Germany

                9.3.2. U.K.

                9.3.3. France

                9.3.4. Spain

                9.3.5. Italy

                9.3.6. Rest of Europe

            9.4. Europe Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

                9.4.1. By Type  

                9.4.2. By Country/Sub-region

    10. Asia Pacific Parenteral Nutrition Market Analysis and Forecast

            10.1. Introduction

                10.1.1. Key Findings

            10.2. Asia Pacific Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

                10.2.1. Carbohydrates

                10.2.2. Parenteral Lipid Emulsions

                10.2.3. Single Dose Amino Acid Solutions 

                10.2.4. Trace Elements, Electrolytes, & Minerals

                10.2.5. Vitamins

            10.3. Asia Pacific Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

                10.3.1. China

                10.3.2. Japan

                10.3.3. India

                10.3.4. Australia & New Zealand

                10.3.5. Rest of Asia Pacific

            10.4. Asia Pacific Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

                10.4.1. By Type  

                10.4.2. By Country/Sub-region

    11. Latin America Parenteral Nutrition Market Analysis and Forecast

            11.1. Introduction

                11.1.1. Key Findings

            11.2. Latin America Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

                11.2.1. Carbohydrates

                11.2.2. Parenteral Lipid Emulsions

                11.2.3. Single Dose Amino Acid Solutions 

                11.2.4. Trace Elements, Electrolytes, & Minerals

                11.2.5. Vitamins

            11.3. Latin America Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

                11.3.1. Brazil

                11.3.2. Mexico

                11.3.3. Rest of Latin America

            11.4. Latin America Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

                11.4.1. By Type  

                11.4.2. By Country/Sub-region

    12. Middle East & Africa Parenteral Nutrition Market Analysis and Forecast

            12.1. Introduction

                12.1.1. Key Findings

            12.2. Middle East & Africa Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

                12.2.1. Carbohydrates

                12.2.2. Parenteral Lipid Emulsions

                12.2.3. Single Dose Amino Acid Solutions 

                12.2.4. Trace Elements, Electrolytes, & Minerals

                12.2.5. Vitamins

            12.3. Middle East & Africa Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

                12.3.1. GCC Countries

                12.3.2. South Africa

                12.3.3. Rest of Middle East & Africa

            12.4. Middle East & Africa Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

                12.4.1. By Type  

                12.4.2. By Country/Sub-region

    13. Competition Landscape

            13.1. Global Parenteral Nutrition Market Player – Competition Matrix (By Tier and Size of companies)

            13.2. Global Parenteral Nutrition Market Share/Position Analysis, by Company (2018)

            13.3. Company Profiles

                13.3.1. Allergan plc.

                         13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.1.2. Company Financials

                         13.3.1.3. Growth Strategies

                         13.3.1.4. SWOT Analysis

                13.3.2. Pfizer Inc.

                         13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.2.2. Company Financials

                         13.3.2.3. Growth Strategies

                         13.3.2.4. SWOT Analysis

                13.3.3. B.Braun Melsungen AG

                         13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.3.2. Company Financials

                         13.3.3.3. Growth Strategies

                         13.3.3.4. SWOT Analysis

                13.3.4. Fresenius Kabi AG

                         13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.4.2. Company Financials

                         13.3.4.3. Growth Strategies

                         13.3.4.4. SWOT Analysis

                13.3.5. Grifols, S.A.

                         13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.5.2. Company Financials

                         13.3.5.3. Growth Strategies

                         13.3.5.4. SWOT Analysis

                13.3.6. Baxter International, Inc.

                         13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.6.2. Company Financials

                         13.3.6.3. Growth Strategies

                         13.3.6.4. SWOT Analysis

                13.3.7. Vifor Pharma Management Ltd.

                         13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.7.2. Company Financials

                         13.3.7.3. Growth Strategies

                         13.3.7.4. SWOT Analysis

                13.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.,

                         13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                         13.3.8.2. Growth Strategies

                         13.3.8.3. SWOT Analysis

    List of Table

    Table 01: Clinical Trial Pipeline Analysis, Parenteral Nutrition Market

    Table 02: Key Merger & Acquisition, Parenteral Nutrition Market

    Table 03: Global Parenteral Nutrition Market Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 04: Global Parenteral Nutrition Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 05: North America Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 06: North America Parenteral Nutrition Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 07: Europe Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 08: Europe Parenteral Nutrition Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 09: Asia Pacific Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 10: Asia Pacific Parenteral Nutrition Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 11: Latin America Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 12: Latin America Parenteral Nutrition Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 13: Middle East & Africa Parenteral Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 14: Middle East & Africa Parenteral Nutrition Value (US$ Mn) Forecast, by Type, 2017–2027

    List of Figure

    Figure 01: Global Parenteral Nutrition Market Value (US$ Mn) Snapshot, by Type, 2018(A)

    Figure 02: Global Parenteral Nutrition Market Snapshot

    Figure 03: Global Parenteral Nutrition Market Share (%) Snapshot, by Region, 2018(A)

    Figure 04: Global Parenteral Nutrition Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

    Figure 05: Global Parenteral Nutrition Market, Opportunity Map, by Type

    Figure 06: Global Parenteral Nutrition Market Value (US$ Mn) Forecast, 2017-2027

    Figure 07: Global Parenteral Nutrition Market Value Share (%), by Type (2018)

    Figure 08: Global Parenteral Nutrition Market Value Share (%), by Region (2018)

    Figure 09: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Pfizer Inc.

    Figure 10: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: B. Braun Melsungen AG

    Figure 11: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Fresenius Kabi AG 

    Figure 12: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Baxter International Inc.

    Figure 13: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Allergan plc.

    Figure 14: Global Parenteral Nutrition Market Clinical Trial Pipeline Analysis: Claris Life Sciences Ltd.

    Figure 15: Parenteral Nutrition Market: Mergers & Acquisitions

    Figure 16: Summary of the Studies on the Prevalence of Non-melanoma skin cancer

    Figure 17: Summary of the Studies on the Prevalence of Lung Cancer

    Figure 18: Summary of the Studies on the Prevalence of Breast Cancer

    Figure 19: Summary of the Studies on the Prevalence of Prostate Cancer

    Figure 20: Summary of the Studies on the Prevalence of Colorectal Cancer

    Figure 21: Prevalence Inflammatory Bowel Disease, by Key Countries (2018)

    Figure 22: Global Preterm Birth Epidemiology Analysis, by Key Countries (2/3)

    Figure 23: Global Preterm Birth Epidemiology Analysis, by Key Countries (2/2)

    Figure 24: Global Parenteral Nutrition Market Value Share Analysis, by Type, 2018 and 2027

    Figure 25: Global Parenteral Nutrition Market Attractiveness, by Type, 2019–2027

    Figure 26: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%)   Projection, by Carbohydrates, 2017–2027                   

    Figure 27: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%)  Projection, by Parenteral Lipid Emulsions, 2017–2027

    Figure 28: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%)  Projection, by Single Dose Amino Acid Solutions, 2017–2027

    Figure 29: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%)  Projection, by Trace Elements, Electrolytes, & Minerals, 2017–2027

    Figure 30: Global Parenteral Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%)  Projection, by Vitamins, 2017–2027

    Figure 31: Global Parenteral Nutrition Market Value Share Analysis, by Region, 2018 and 2027

    Figure 32: Global Parenteral Nutrition Market Attractiveness, by Region, 2019–2027

    Figure 33: North America Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast,  2017–2027

    Figure 34: North America Parenteral Nutrition Market Value Share (%), by Country, 2018 and 2027

    Figure 35: North America Parenteral Nutrition Market Attractiveness, by Country, 2019–2027

    Figure 36: North America Parenteral Nutrition Market Value Share (%), by Type, 2018 and 2027

    Figure 37: North America Parenteral Nutrition Market Attractiveness, by Type, 2019–2027

    Figure 38: Europe Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027

    Figure 39: Europe Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 40: Europe Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 41: Europe Parenteral Nutrition Market Value Share (%), by Type, 2018 and 2027

    Figure 42: Europe Parenteral Nutrition Market Attractiveness, by Type, 2019–2027

    Figure 43: Asia Pacific Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 44: Asia Pacific Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 45: Asia Pacific Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 46: Asia Pacific Parenteral Nutrition Market Value Share (%), by Type, 2018 and 2027

    Figure 47: Asia Pacific Parenteral Nutrition Market Attractiveness, by Type, 2019–2027

    Figure 48: Latin America Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 49: Latin America Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 50: Latin America Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 51: Latin America Parenteral Nutrition Market Value Share (%), by Type, 2018 and 2027

    Figure 52: Latin America Parenteral Nutrition Market Attractiveness, by Type, 2019–2027

    Figure 53: Middle East & Africa Parenteral Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 54: Middle East & Africa Parenteral Nutrition Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 55: Middle East & Africa Parenteral Nutrition Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 56: Middle East & Africa Parenteral Nutrition Market Value Share (%), by Type, 2018  and 2027

    Figure 57: Middle East & Africa Parenteral Nutrition Market Attractiveness, by Type, 2019–2027

    Figure 58: Global Parenteral Nutrition Market Share/Position Analysis, by Company (2018)

    Figure 59: Allergan plc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 60: Allergan plc., Breakdown of Net Sales, by Business Segment (2018)

    Figure 61: Allergan plc., R&D Intensity and Sales & Marketing Intensity – Company Level, 2015–2018

    Figure 62: Allergan plc., Breakdown of Net Sales, by Region (2018)

    Figure 63: Pfizer Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 64: Pfizer Inc., Breakdown of Net Sales, by Business Segment (2018)

    Figure 65: Pfizer Inc., R&D Intensity and Sales & Marketing Intensity – Company Level, 2015–2018

    Figure 66: Pfizer Inc., Breakdown of Net Sales, by Region, (2018)

    Figure 67: B. Braun Melsungen AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 68: B. Braun Melsungen AG, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 69: B. Braun Melsungen AG, Breakdown of Net Sales, by Business Segment (2018)

    Figure 70: B. Braun Melsungen AG, Breakdown of Net Sales, by Region (2018)

    Figure 71: Fresenius Kabi AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 72: Fresenius Kabi AG, Breakdown of Net Sales, by Region (2018)

    Figure 73: Fresenius Kabi AG, Breakdown of Net Sales, by Segment (2018)

    Figure 74: Fresenius Kabi AG, Research & Development Cost (US$ Mn), 2015 - 2018 

    Figure 75: Grifols, S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 76: Grifols, S.A., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 77: Grifols, S.A., Breakdown of Net Sales (%), by Business Segment (2018)

    Figure 78: Grifols, S.A., Breakdown of Net Sales (%), by Region (2018)

    Figure 79: Baxter International, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 80: Baxter International, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 81: Baxter International, Inc., Breakdown of Net Sales, by Region (2018)

    Figure 82: Baxter International, Inc., Breakdown of Net Sales (%), by Business Segment (2018)

    Figure 83: Vifor Pharma Management Ltd., Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2018

    Figure 84: Vifor Pharma Management Ltd., Revenue Breakdown of Net Sales, by Business Segment (2018)

    Figure 85: Vifor Pharma Management Ltd., Revenue Breakdown of Net Sales, by Region (2018)

    Figure 86: Vifor Pharma Management Ltd., R&D Intensity and Sales & Marketing Intensity – Company Level, 2015–2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Parenteral Nutrition Market Insights, 2019-2027

Schedule a Call